Iodixanol-Loaded Thermosensitive Liposomes: A Novel Imaging Contrast Agent for Precision Hepatocellular Carcinoma Ablation
- PMID: 40446202
- DOI: 10.1021/acs.molpharmaceut.5c00527
Iodixanol-Loaded Thermosensitive Liposomes: A Novel Imaging Contrast Agent for Precision Hepatocellular Carcinoma Ablation
Abstract
In hepatocellular carcinoma ablation, unclear tumor boundaries and localization often lead to incomplete treatment. Traditional iodinated contrast agents, although effective in distinguishing tumors, have rapid metabolism, limiting sustained visualization during ablation. Iodixanol-loaded thermosensitive liposomes were prepared by using the thin-film hydration method. Their temperature-responsive properties and CT imaging performance were validated through in vitro experiments, while in vivo studies were conducted to evaluate their CT imaging efficacy and potential as an auxiliary imaging agent in ablation therapy. This study successfully created stable, iodixanol-loaded thermosensitive liposomes that effectively outline HCC boundaries and accurately show the ablation zone during treatment. Iodixanol-loaded thermosensitive liposomes enable precise localization of ablation margins, facilitating more accurate clinical assessment of therapeutic outcomes and treatment end points.
Keywords: ablation; computed tomography; hepatocellular carcinoma; image navigation; thermosensitive liposomes.
Similar articles
-
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2. Cochrane Database Syst Rev. 2022. PMID: 36053210 Free PMC article.
-
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2. Cochrane Database Syst Rev. 2021. PMID: 34611889 Free PMC article.
-
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2. Cochrane Database Syst Rev. 2017. PMID: 28351116 Free PMC article.
-
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2. Cochrane Database Syst Rev. 2022. PMID: 35521901 Free PMC article.
-
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221. Health Technol Assess. 2023. PMID: 38149643 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical